Vmos, Mgmt never said they would report on sensitivity and specificity. Don't forget there will be more insights released as they process the data. Analysing 2X data sets (Initial & Follow Up scans) together with the ground truths for 150-200 patients is quite a large task.
Also refer to the following statement in the last quarterly.
"The interim stroke diagnostic performance aligned with expectations following first deployment of emuTM in this front door study of a wide variety of acute strokes and mimics, providing confidence in achieving desirable validation (sensitivity/specificity) outcomes. An abstract related to the Stage 2 insights has been accepted for the 10th European Stroke Organisation Conference (ESOC 2024) in Basel, Switzerland in May."
EMV Price at posting:
$2.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)